Dr. Dana Carroll to Deliver Keynote on Challenges in Programmable Genome Editing in San Diego
2nd Annual Genome Editing & Engineering Conference to be held on 6th – 7th February 2017 in San Diego, CA will see participation from global experts from pharmaceutical, bio-pharmaceutical companies, universities and academic institutions. The conference will look into various genome editing tools like CRISPR/Cas9 and TALENs and the potential they hold in developing biomedical and therapeutic applications.
The conference will gather key industry leaders and researchers from research institutes, academic institutions, pharma and bio–pharma organizations to address the concepts, challenges and applications of genome editing tools like CRISPR/Cas9, TALENs. Key discussions at the event will include RNA guided nuclease for genome modifications, different gene delivery systems, CRISPR as a molecular tool for programmable gene expression and gene therapy, human gene therapy using Zebrafish model, gene knock in and genomic screening using TALEN and CRISPR, CRISPR biomedical research applications, RNAi based screening technologies, genome editing for disease modeling and NgAgo as the latest tool for genome editing.
The marketing team at MarketsandMarkets did a small pre–event interview with Dr. Carroll, talking about the emerging research areas in genome editing and engineering for the treatment of disorders. Dr. Carroll mentioned a few areas where gene editing has been instrumental in finding results namely “Improvement of the efficiency of homologous repair to allow easy gene correction’, ‘Delivery methods for in vivo treatments” and “Development of ‘universal’ donor cells to allow more affordable treatments.” He further added, “Genome editing depends on cellular DNA repair activities, so research on aspects of genome editing will help us learn more about those activities.”
Joining him on the speaker panel will be genomics experts representing organizations such as University of Utah School of Medicine, Massachusetts Institute of Technology, J. Craig Venter Institute, University of Nebraska Medical Center, University of California, University of Washington, University of Southern California, University of Rochester, National Institutes of Health, University of Texas, University of Minnesota, Hiroshima University and Wellcome Trust Sanger Institute.
The conference will be an excellent opportunity to network, share expertise with industry peers and stay updated about the latest advancements in genomics and gene engineering. The conference is supported by California Life Sciences Association (CLSA), ArizonaBio, BioUtah, Colorado BioScience Association, Georgia Bio, Northwest Association for Biomedical Research (NWABR) and The Bioscience Association of Maine (BAM). The event is co-located with the 2nd Annual Biomarker Conference and 2nd Annual NGS Data Analysis and Informatics Conference and is scheduled for 6th – 7th February 2017.